Glycan changes: Cancer metastasis and anti-cancer vaccines

Journal of Biosciences

Volumn 35, Issue 4, 2010, Pages 665-673

  Li, Min ^a   Song, Lujun ^a   Qin, Xinyu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Anti cancer vaccines; cancer; glycan; glycosylation; metastatis; therapy

Indexed keywords

ALPHA FETOPROTEIN; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; CANCER VACCINE; CARBOHYDRATE; GALECTIN; GLYCAN; GLYCOGEN SYNTHASE KINASE; GLYCOPEPTIDASE; GLYCOSIDE; GLYCOSPHINGOLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE; INTERLEUKIN 21; LIPOPEPTIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUCIN 1; N ALPHA DEXTRO GLUCOPYRANOSIDE SALICYLOYL HYDRAZINE; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; SELECTIN; SIALIC ACID; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG; UVOMORULIN;

CANCER; CARBOHYDRATE; TUMOR; VACCINE;

ANTIGEN STRUCTURE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOIMMUNITY; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CELL ADHESION; CELL COMMUNICATION; CELL PROLIFERATION; COLON CANCER; DRUG HALF LIFE; EPITHELIAL MESENCHYMAL TRANSITION; GLYCOSYLATION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE RESPONSE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; ONCOGENESIS AND MALIGNANT TRANSFORMATION; POLYMERIZATION; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; TUMOR CELL; UNSPECIFIED SIDE EFFECT;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CANCER VACCINES; CELL MEMBRANE; GALECTINS; GLYCOSPHINGOLIPIDS; GLYCOSYLATION; GPI-LINKED PROTEINS; HUMANS; MOLECULAR TARGETED THERAPY; N-ACETYLNEURAMINIC ACID; NEOPLASM METASTASIS; POLYSACCHARIDES; SELECTINS; TUMOR MARKERS, BIOLOGICAL;

EID: 78651273016     PISSN: 02505991     EISSN: 02505991     Source Type: Journal    
DOI: 10.1007/s12038-010-0073-8     Document Type: Review

References (94)

1. T. Ariga K. Suetake M. Nakane M. Kubota S. Usuki I. Kawashima R. K. Yu 2009 Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors Neurosignals 17 226 234
2. J. N. Arnold R. Saldova U. Hamid P. M. Rudd 2008 Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation Proteomics 8 3284 3293 1:CAS:528:DC%2BD1cXhtVGqs7%2FK 10.1002/pmic.200800163 18646009
3. A. K. Azab J. Kleinstern M. Srebnik A. Rubinstein 2008 The metastatic stage-dependent mucosal expression of sialic acid is a potential marker for targeting colon cancer with cationic polymers Pharm. Res. 25 379 386 1:CAS:528:DC%2BD1cXitVejtrk%3D 10.1007/s11095-007-9330-4 17960470 (Pubitemid 351257965)
4. M. Bektas S. Spiegel 2003 Glycosphingolipids and cell death Glycoconjugate J. 20 39 47 10.1023/B:GLYC.0000016741.88476.8b
5. I. Bettahi G. Dasgupta O. Renaudet A. ChentoufiA X. L. Zhang D. Carpenter S. Yoon P. Dumy L. BenMohamed 2009 Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4(+) nd CD8(+) T cell epitopes Cancer Immunol. Immun. 58 187 200 1:CAS:528:DC%2BD1cXhtl2lsLzO
6. I. Brockhausen 1999 Pathways of O-glycan biosynthesis in cancer cells Bba-Gen Subjects 1473 67 95 1:CAS:528:DyaK1MXnsVKmt7c%3D 10.1016/S0304-4165(99) 00170-1
7. Buskas T, Thompson P and Boons G J 2009 Immunotherapy for cancer: synthetic carbohydrate-based vaccines; Chem. Commun. No. 36, 5335-5349
8. N. Ceaglio M. Etcheverrigaray H. S. Conradt N. Grammel R. Kratje M. Oggero 2010 Highly glycosylated human alpha interferon: An insight into a new therapeutic candidate J. Biotechnol. 146 74 83 1:CAS:528:DC%2BC3cXis1WgsL0%3D 10.1016/j.jbiotec.2009.12.020 20067809
9. A. ChentoufiA A. B. Nesburn L. BenMohamed 2009 Recent advances in multivalent self adjuvanting glycolipopeptide vaccine strategies against breast cancer Arch. Immunol. Ther. Ex. 57 409 423 10.1007/s00005-009-0049-2
10. J. N. Contessa M. S. Bhojani H. H. Freeze B. D. Ross A. Rehemtulla T. S. Lawrence 2010 Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy Clin. Cancer Res. 16 3205 3214 1:CAS:528:DC%2BC3cXntlKru7c%3D 10.1158/1078-0432.CCR-09-3331 20413434
11. J. H. Cummings A. M. Stephen 2007 Carbohydrate terminology and classification Eur. J. Clin. Nutr. 61 Suppl.1 S5 S18 1:CAS:528: DC%2BD2sXht1OqsrvJ 10.1038/sj.ejcn.1602936 17992187 (Pubitemid 350104360)
12. E. Dabelsteen 1996 Cell surface carbohydrates as prognostic markers in human carcinomas J Pathol. 179 358 369 1:STN:280:DyaK2s%2Fit12hsw%3D%3D 10.1002/(SICI)1096-9896(199608)179:4<358::AID-PATH564>3.0.CO;2-T 8869281 (Pubitemid 26276103)
13. T. Deguchi M. Tanemura E. Miyoshi H. Nagano T. Machida Y. Ohmura S. Kobayashi S. Marubashi, et al. 2010 Increased immunogenicity of tumor-associated antigen, Mucin 1, engineered to EXPRESS alpha-Gal epitopes: a novel approach to immunotherapy in pancreatic cancer Cancer Res. 70 5259 5269 1:CAS:528:DC%2BC3cXot1Wlu70%3D 10.1158/0008-5472.CAN-09-4313 20530670
14. M. Demers A. Rose A. A. Grosset K. Biron-Pain L. Gaboury P. M. Siegel Y. St-Pierre 2010 Overexpression of galectin-7, A myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells Am. J. Pathol. 176 3023 3031 1:CAS:528:DC%2BC3cXptFKrtr0%3D 10.2353/ajpath.2010.090876 20382700
15. J. W. Dennis M. Granovsky C. E. Warren 1999 Glycoprotein glycosylation and cancer progression BBA-Gene Subjects 1473 21 34 1:CAS:528:DyaK1MXnsVKmt7g%3D 10.1016/S0304-4165(99)00167-1
16. M. V. Dwek S. A. Brooks 2004 Harnessing changes in cellular glycosylation in new cancer treatment strategies Curr. Cancer Drug Tar. 4 425 442 1:CAS:528:DC%2BD2cXntVKgsrs%3D 10.2174/1568009043332899 (Pubitemid 39100026)
17. FAO 1998 Carbhohydrates in human nutrition, Food and Agriculture Organization of the United Nations, Rome; Report of a Joint FAO/WHO Expert Consultation. FAO Food and Nutrition Paper no. 66
18. M. M. Fuster J. D. Esko 2005 The sweet and sour of cancer: Glycans as novel therapeutic targets Nat. Rev. Cancer 5 526 542 1:CAS:528: DC%2BD2MXmtFOnsL4%3D 10.1038/nrc1649 16069816 (Pubitemid 40942829)
19. B. Gallegos E. Perez-Campos R. Martinez P. Leyva M. Martinez R. Hernandez S. Pina C. Hernandez E. Zenteno P. Hernandez 2010 O-glycosylation expression in fibroadenoma Prep. Biochem. Biotech. 40 1 12 1:CAS:528:DC%2BD1MXhsFOns7nL 10.1080/10826060903386071
20. G. Garcea M. M. Manson C. P. Neal C. J. Pattenden C. D. Sutton A. R. Dennison D. P. Berry 2007 Glycogen synthase kinase-3 beta; A new target in pancreatic cancer? Curr. Cancer Drug Tar. 7 209 215 1:CAS:528: DC%2BD2sXlsFCrtr0%3D 10.2174/156800907780618266 (Pubitemid 46699072)
21. S. F. Gilbert 2009 Ageing and cancer as diseases of epigenesis J. Biosci. 34 601 604 1:CAS:528:DC%2BD1MXhs1Wit7bE 10.1007/s12038-009-0077-4 19920344
22. K. Goswami H. Nandeesha B. Koner D. Nandakumar 2007 A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis Prostate Cancer P. D. 10 356 359 1:CAS:528:DC%2BD2sXhtlKmur3F 10.1038/sj.pcan.4500965 (Pubitemid 350238084)
23. J. Gu Y. Sato Y. Kariya T. Isaji N. Taniguchi T. Fukuda 2009 A mutual regulation between cell-cell adhesion and N-glycosylation: Implication of the bisecting GlcNAc for biological functions J. Proteome Res. 8 431 435 1:CAS:528:DC%2BD1cXhsVKis7zO 10.1021/pr800674g 19053837
24. S. I. Hakomori 2008 Structure and function of glycosphingolipids and sphingolipids: Recollections and future trends BBA-Gene Subjects 1780 325 346 1:CAS:528:DC%2BD1cXjsVSisL4%3D 10.1016/j.bbagen.2007.08.015 (Pubitemid 351395304)
25. S. Hakomori 2010 Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility FEBS Lett. 584 1901 1906 1:CAS:528:DC%2BC3cXkvFOjsro%3D 10.1016/j.febslet.2009.10.065 19874824
26. X. T. He M. J. Hannocks I. Hampson G. Brunner 2002 GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy Clin. Exp. Metastas. 19 291 299 10.1023/A:1015545407700 (Pubitemid 34606754)
27. M. Hebbar A. Adenis F. Revillion A. Duhamel O. Romano S. Truant C. Libersa C. Giraud, et al. 2009 E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer Eur. J. Cancer 45 1871 1876 1:CAS:528:DC%2BD1MXnsV2ksr8%3D 10.1016/j.ejca.2009.03.011 19361981
28. M. Hedlund E. Ng A. Varki N. M. Varki 2008 alpha 2-6-linked sialic acids on N-glycans modulate carcinoma differentiation in vivo Cancer Res. 68 388 394 1:CAS:528:DC%2BD1cXmt1Onsg%3D%3D 10.1158/0008-5472.CAN-07-1340 18199532 (Pubitemid 351380065)
29. D. C. Hoessli S. Tauzin Nasir-ud-Din B. Borisch 2007 Functional and structural roles of GPI moieties in mammalian plasma membranes Curr. Org. Chem. 11 619 626 1:CAS:528:DC%2BD2sXkslGgtLo%3D 10.2174/138527207780598783 (Pubitemid 46746345)
30. S. Honda S. Suzuki A. Taga 2003 Analysis of carbohydrates as 1-phenyl-3-methyl-5-pyrazolone derivatives by capillary/microchip electrophoresis and capillary electrochromatography J. Pharmaceut. Biomed. 30 1689 1714 1:CAS:528:DC%2BD38XpsFWiur8%3D 10.1016/S0731-7085(02)00512-5 (Pubitemid 35453973)
31. G. C. Huang L. B. Chen 2010 Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma J. Cancer Res. Clin. 136 1201 1211 1:CAS:528:DC%2BC3cXns1ylsbw%3D 10.1007/s00432-010-0770-6
32. P. A. Iacovazzi M. Notarnicola M. G. Caruso V. Guerra S. Frisullo D. F. Altomare M. Correale 2010 Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients Immunopharm. Immunot. 32 160 164 1:CAS:528:DC%2BC3cXitlWmtbk%3D 10.3109/08923970902936880
33. Y. Igarashi R. Kannagi 2010 Glycosphingolipids as mediators of phenotypic changes associated with development and cancer progression J. Biochem. 147 3 8 1:CAS:528:DC%2BC3cXkt1KntA%3D%3D 10.1093/jb/mvp195 20051388
34. W. W. Jiang M. Zahurak Z. T. Zhou H. L. Park Z. M. Guo G. J. Wu D. Sidransky B. Trink J. A. Califano 2007 Alterations of GPI transamidase subunits in head and neck squamous carcinoma Mol. Cancer 6 74 10.1186/1476-4598-6-74 18028549
35. T. Jian-Hua H. Wang-Jiao H. He T. Chao-Chao D. Qiong W. Kai-Jia Y. Xian-Yu Z. Xu-Jin 2009 Important roles of glycosyl phosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma Clin. Biochem. 42 400 407 10.1016/j.clinbiochem.2008.11.019
36. T. Z. Ju G. S. Lanneau T. Gautam Y. C. Wang B. Y. Xia S. R. Stowell M. T. Willard W. Y. Wang, et al. 2008 Human tumor antigens to and sialyl Tn arise from mutations in Cosmc Cancer Res. 68 1636 1646 1:CAS:528:DC%2BD1cXjtFOhsrg%3D 10.1158/0008-5472.CAN-07-2345 18339842 (Pubitemid 351416547)
37. A. Kaiser N. Gaidzik U. Westerlind D. Kowalczyk A. Hobel E. Schmitt H. Kunz 2009 A synthetic vaccine consisting of a tumor-associated sialyl-T-N-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response Angew. Chem. Int. Edit. 48 7551 7555 1:CAS:528:DC%2BD1MXht1Sru7zN 10.1002/anie.200902564
38. C. Kazezoglu S. S. Gokmen B. Sunar C. Aygit B. Cakir 2007 Serum total and lipid bound sialic acid levels in patients with benign and nonmelanom malignant skin tumors Turk. J. Biochem. 32 17 21 1:CAS:528:DC%2BD2sXpslegtbc%3D
39. S. J. Kim I. J. Choi T. C. Cheong S. J. Lee R. Lotan S. H. Park K. H. Chun 2010 Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression Gastroenterology 138 1035 1308 1:CAS:528: DC%2BC3cXksVCrtL4%3D 10.1053/j.gastro.2009.09.061 19818782
40. Y. S. Kim H. S. Yoo J. H. Ko 2009 Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery Protein Peptide Lett. 16 499 507 1:CAS:528:DC%2BD1MXmvVCrt7s%3D 10.2174/092986609788167798
41. S. Kitazume R. Imamaki K. Ogawa Y. Komi S. Futakawa S. Kojima Y. Hashimoto J. D. Marth J. C. Paulson N. Taniguchi 2010 Alpha 2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling J. Biol. Chem. 285 6515 6521 1:CAS:528:DC%2BC3cXit1aisLY%3D 10.1074/jbc.M109.073106 20048157
42. M. Knas S. D. Szajda J. Snarska B. Zalewska-Szajda P. Walejko M. Borzym-Kluczyk K. Knas-Karaszewska A. Kepka, et al. 2009 Colon Cancer Releases alpha-Tocopherol from Its O-Glycosides Better Than Normal Colon Tissue Hepato-Gastroenterol. 56 339 342 1:CAS:528:DC%2BD1MXmsVaqu7g%3D
43. D. J. Laderach D. Compagno M. A. Toscano D. O. Croci S. Dergan-Dylon M. Salatino G. A. Rabinovich 2010 Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings Iubmb Life 62 1 13 1:CAS:528:DC%2BC3cXktlemsA%3D%3D 20014236
44. S. Lahiri A. H. Futerman 2007 The metabolism and function of sphingolipids and glycosphingolipids Cell Mol. Life Sci. 64 2270 2284 1:CAS:528:DC%2BD2sXhtFygtr3L 10.1007/s00018-007-7076-0 17558466 (Pubitemid 47347954)
45. H. Laubli J. L. Stevenson A. Varki N. M. Varki L. Borsig 2006 L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest Cancer Res. 66 1536 1542 10.1158/0008-5472.CAN- 05-3121 16452210 (Pubitemid 43259935)
46. M. Le Mercier S. Fortin V. Mathieu R. Kiss F. Lefranc 2010 Galectins and gliomas Brain Pathol. 20 17 27 10.1111/j.1750-3639.2009.00270.x 19371355
47. L. M. Li W. K. Ching T. Yamaguchi K. F. Aoki-Kinoshita 2010 A weighted q-gram method for glycan structure classification BMC Bioinformatics 11 Suppl.1 S33 10.1186/1471-2105-11-S1-S33 20122206
48. A. Liakatos H. Kunz 2007 Synthetic glycopeptides for the development of cancer vaccines Curr. Opin. Mol. Ther. 9 35 44 1:CAS:528:DC%2BD2sXjt1Sgsb0%3D 17330400
49. P. H. Liang C. Y. Wu W. A. Greenberg C. H. Wong 2008 Glycan arrays: biological and medical applications Curr. Opin. Chem. Biol. 12 86 92 1:CAS:528:DC%2BD1cXktFelt70%3D 10.1016/j.cbpa.2008.01.031 18258211
50. E. Marth G. Flaschka S. Stiegler J. Mose 1988 Sialic acid as a marker for differentiation between benign and malignant intracranial tumors Clin. Chim. Acta 176 251 258 1:CAS:528:DyaL1cXmtVOrurs%3D 10.1016/0009-8981(88)90184-2 3180477
51. M. A. Mayoral C. Mayoral A. Meneses L. Villalvazo A. Guzman B. Espinosa J. L. Ochoa E. Zenteno J. Guevara 2008 Identification of Galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain Cancer Invest. 26 615 623 1:CAS:528:DC%2BD1cXnsl2rt7Y%3D 10.1080/07357900701837051 18584353 (Pubitemid 351918585)
52. K. McCluskey A. Wiest M. Plamann 2010 The Fungal Genetics Stock Center: a repository for 50 years of fungal genetics research J. Biosci. 35 119 126 1:CAS:528:DC%2BC3cXps1WksL8%3D 10.1007/s12038-010-0014-6 20413916
53. E. Meyts S. N. Poll I. Goukasian C. Jeanneau A. S. Herlihy E. P. Bennett N. E. Skakkebaek H. Clausen A. Giwercman U. Mandel 2007 Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation Virchows Arch. 451 805 814 10.1007/s00428-007-0478-4 (Pubitemid 47497945)
54. D. H. Mi Y. G. Gao S. Zheng X. Q. Ba X. L. Zeng 2009 Inhibitory effects of chemically modified heparin on the P-selectinmediated adhesion of breast cancer cells in vitro Mol. Med. Reports 2 301 306 1:CAS:528:DC%2BD1MXis1agtbs%3D
55. K. Nagao Y. Itoh K. Fujita M. Fujime 2007 Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes Int. J. Urol. 14 795 799 1:CAS:528:DC%2BD2sXhtF2qs7rI 10.1111/j.1442-2042.2007.01840.x 17760744 (Pubitemid 47313283)
56. K. Ohtsubo J. D. Marth 2006 Glycosylation in cellular mechanisms of health and disease Cell 126 855 867 1:CAS:528:DC%2BD28XpvVKitbo%3D 10.1016/j.cell.2006.08.019 16959566 (Pubitemid 44310784)
57. O. Oyelaran J. C. Gildersleeve 2007 Application of carbohydrate array technology to antigen discovery and vaccine development Expert Rev. Vaccines 6 957 969 1:CAS:528:DC%2BD1cXms1Sitg%3D%3D 10.1586/14760584.6.6.957 18377358 (Pubitemid 350260659)
58. G. Patsos V. Hebbe-Viton C. Robbe-Masselot D. Masselot R. S. Martin R. Greenwood C. Paraskeva A. Klein, et al. 2009 O-Glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines Glycobiology 19 382 398 1:CAS:528:DC%2BD1MXivFSntbo%3D 10.1093/glycob/cwn149 19122213
59. R. Peracaula S. Barrabes A. Sarrats P. M. Rudd R. de Llorens 2008 Altered glycosylation in tumours focused to cancer diagnosis Dis. Markers 25 207 218 1:CAS:528:DC%2BD1MXhsVOiug%3D%3D 19126965
60. S. S. Pinho H. Osorio M. Nita-Lazar J. Gomes C. Lopes F. Gartner C. A. Reis 2009 Role of E-cadherin N-glycosylation profile in a mammary tumor model Biochem. Biophs. Res. Commun. 379 1091 1096 1:CAS:528:DC%2BD1MXhs1anu7k%3D 10.1016/j.bbrc.2009.01.024
61. S. Pizette C. Rabouille S. M. Cohen P. Therond 2009 Glycosphingolipids control the extracellular gradient of the Drosophila EGFR ligand Gurken Development 136 551 561 1:CAS:528:DC%2BD1MXjsFKgtLw%3D 10.1242/dev.031104 19144719
62. G. A. Rabinovich M. A. Toscanol S. S. Jackson G. R. Vasta 2007 Functions of cell surface galectin-glycoprotein lattices Curr. Opin. Struc. Biol. 17 513 520 1:CAS:528:DC%2BD2sXht1KktbbF 10.1016/j.sbi.2007.09.002 (Pubitemid 350019014)
63. I. A. Radichev A. G. Remacle S. A. Shiryaev A. N. Purves S. L. Johnson M. Pellecchia A. Y. Strongin 2010 Biochemical characterization of the cellular glycosylphosphatidylinosito l-linked membrane type-6 matrix metalloproteinase J. Biol. Chem. 285 16076 16086 1:CAS:528:DC%2BC3cXmtVykt7o%3D 10.1074/jbc.M110. 107094 20308072
64. C. A. Reis H. Osorio L. Silva C. Gomes L. David 2010 Alterations in glycosylation as biomarkers for cancer detection J. Clin. Pathol. 63 322 329 1:CAS:528:DC%2BC3cXmtFOmsb4%3D 10.1136/jcp.2009.071035 20354203
65. A. Rose A. A. Grosset Z. F. Dong C. Russo P. A. MacDonald N. R. Bertos Y. St-Pierre R. Simantov, et al. 2010 Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer Clin. Cancer Res. 16 2147 2156 1:CAS:528:DC%2BC3cXktFyns7o%3D 10.1158/1078-0432.CCR-09-1611 20215530
66. P. M. Rudd T. Elliott P. Cresswell I. A. Wilson R. A. Dwek 2001 Glycosylation and the immune system Science 291 2370 2376 1:CAS:528: DC%2BD3MXit1Knsb4%3D 10.1126/science.291.5512.2370 11269318 (Pubitemid 32231792)
67. U. Sattler F. Hirschhaeuser W. F. Mueller-Klieser 2010 Manipulation of Glycolysis in Malignant Tumors: Fantasy or Therapy? Curr. Med. Chem. 17 96 108 1:CAS:528:DC%2BC3cXhsVSmtrs%3D 10.2174/092986710790112657 19941476
68. R. Scatena P. Bottoni A. Pontoglio L. Mastrototaro B. Giardina 2008 Glycolytic enzyme inhibitors in cancer treatment Expert Opin. Inv. Drug. 17 1533 1545 1:CAS:528:DC%2BD1cXhtFCjurrP 10.1517/13543784.17.10.1533
69. P. Sozzani R. Arisio M. Porpiglia C. Benedetto 2008 Is sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer? Int. J. Surg. Pathol. 16 365 374 10.1177/1066896908324668 18977761
70. Q. Sun C. R. Weber A. Sohail M. M. Bernardo M. Toth H. Zhao J. R. Turner R. Fridman 2007 MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties J. Biol. Chem. 282 21998 22010 1:CAS:528:DC%2BD2sXotVGls7g%3D 10.1074/jbc.M701737200 17513868 (Pubitemid 47195749)
71. A. Takada K. Ohmori T. Yoneda K. Tsuyuoka A. Hasegawa M. Kiso R. Kannagi 1993 Contribution of carbohydrate antigens Sialyl Lewis-A and Sialyl Lewis-X to adhesion of human cancer-cells to vascular endothelium Cancer Res. 53 354 361 1:CAS:528:DyaK3sXnvVaqsA%3D%3D 7678075
72. C. K. Tang M. Katsara V. Apostolopoulos 2008 Strategies used for MUC1 immunotherapy: human clinical studies Expert Rev. Vaccines 7 963 975 1:CAS:528:DC%2BD1cXhtVOiur%2FP 10.1586/14760584.7.7.963 18767946
73. S. N. Thomas R. L. Schnaar K. Konstantopoulos 2009 Podocalyxinlike protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells Am. J Physiol.-Cell Physiol. 296 C505 C513 1:CAS:528:DC%2BD1MXjtFGrsLc%3D 10.1152/ajpcell.00472.2008 19118161
74. L. F. Tietze J. M. von Hof B. Krewer M. Mueller F. Major H. J. Schuster I. Schuberth F. Alves 2008 Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy Chemmedchem 3 1946 1955 1:CAS:528:DC%2BD1MXosVSm 10.1002/cmdc.200800250 19021160
75. M. Ugorski A. Laskowska 2002 Sialyl Lewis(a): a tumorassociated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells Acta Biochim. Pol. 49 303 311 1:CAS:528:DC%2BD38XlsFCrtbo%3D 12362971
76. Varki A, Kannagi R and Toole B P 2009 Glycosylation changes in cancer; in Essentials of glycobiology, 2nd edition, (eds.) A Varki, R D Cummings, J D Esko, H H Freeze, P Stanley, C R Bertozzi, G W Hart and M E Etzler (New York: Cold Spring Harbor Laboratory Press) pp 580-670
77. N. M. Varki A. Varki 2007 Diversity in cell surface sialic acid presentations: implications for biology and disease Lab. Invest. 87 851 857 1:CAS:528:DC%2BD2sXptFensbg%3D 10.1038/labinvest.3700656 17632542 (Pubitemid 47267816)
78. G. H. Waetzig A. Chalaris P. Rosenstiel J. Suthaus C. Holland N. Karl L. V. Uriarte A. Till, et al. 2010 N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130 J. Biol. Chem. 285 1781 1789 1:CAS:528:DC%2BC3cXjsVSlsA%3D%3D 10.1074/jbc.M109.075952 19915009
79. F. L. Wang S. X. Cui L. P. Sun X. J. Qu Y. Y. Xie L. Zhou Y. L. Mu W. Tang Y. S. Wang 2009 High expression of alpha 2, 3-linked sialic acid residues is associated with the metastatic potential of human gastric cancer Cancer Detect. Prev. 32 437 443 1:CAS:528:DC%2BD1MXht1Giur%2FO 10.1016/j.cdp.2009.01. 001 19232843
80. L. Y. Wang Y. L. Liang Z. X. Li X. M. Cai W. Zhang G. Q. Wu J. W. In Z. Y. Fang Y. Yang X. L. Zha 2007 Increase in beta 1-6 GlcNAc branching caused by N-acetylglucosaminyltransferase V directs integrin beta 1 stability in human hepatocellular carcinoma cell line SMMC-7721 J. Cell Biochem. 100 230 241 1:CAS:528:DC%2BD2sXjvVag 10.1002/jcb.21071 16924681 (Pubitemid 44958193)
81. I. P. Witz 2008 The selectin-selectin ligand axis in tumor progression Cancer Metast. Rev. 27 19 30 1:CAS:528:DC%2BD1cXhtV2guro%3D 10.1007/s10555-007- 9101-z
82. M. H. Wu T. M. Hong H. W. Cheng S. H. Pan Y. R. Liang H. C. Hong W. F. Chiang T. Y. Wong, et al. 2009 Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons Mol. Cancer Res. 7 311 318 1:CAS:528:DC%2BD1MXjtF2js78%3D 10.1158/1541-7786.MCR-08-0297 19276182
83. Y. M. Wu D. D. Nowack G. S. Omenn B. B. Haab 2009 Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells J. Proteome Res. 8 1876 1886 1:CAS:528:DC%2BD1MXit1Wgu7s%3D 10.1021/pr8008379 19714813
84. Y. Xu L. Zhang G. X. Hu 2009 Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis Biologicals 37 18 25 10.1016/j.biologicals.2008.08.002 18848467
85. S. J. Yeung J. Pan M. H. Lee 2008 Roles of p53, Myc and HIF-1 in Regulating Glycolysis - the Seventh Hallmark of Cancer Cell Mol. Life Sci. 65 3981 3999 1:CAS:528:DC%2BD1cXhsFCgs7nF 10.1007/s00018-008-8224-x 18766298
86. J. K. Yi J. W. Chang W. Han J. W. Lee E. Ko D. H. Kim J. Y. Bae J. Yu, et al. 2009 Autoantibody to Tumor Antigen, Alpha 2-HS Glycoprotein: A Novel Biomarker of Breast Cancer Screening and Diagnosis Cancer Epidem. Biomar. 18 1357 1364 1:CAS:528:DC%2BD1MXlsFCltrs%3D 10.1158/1055-9965.EPI-08-0696
87. A. Yusa K. Miyazaki N. Kimura M. Izawa R. Kannagi 2010 Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewis(x) expression and accelerates Proliferation of Colon Cancer Cells Cancer Res. 70 4064 4073 1:CAS:528:DC%2BC3cXlvFyqsrk%3D 10.1158/0008-5472.CAN-09-2383 20460514
88. A. Zarbock R. K. Polanowska-Grabowska K. Ley 2007 Plateletneutrophil- interactions: Linking hemostasis and inflammation Blood Rev. 21 99 111 1:CAS:528:DC%2BD2sXlsFGlu7Y%3D 10.1016/j.blre.2006.06.001 16987572 (Pubitemid 46428465)
89. R. B. Zavareh K. S. Lau R. Hurren A. Datti D. J. Ashline M. Gronda P. Cheung C. D. Simpson, et al. 2008 Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function Cancer Res. 68 6688 6697 1:CAS:528:DC%2BD1cXpslKms7Y%3D 10.1158/0008-5472.CAN-07-6833
90. K. Zen D. Q. Liu Y. L. Guo C. Wang J. Shan M. Fang C. Y. Zhang Y. Liu 2008 CD44v4 Is a major E-selectin ligand that mediates breast cancer cell transendothelial migration PLOS One 3 e1826 10.1371/journal.pone.0001826 18350162 (Pubitemid 351936291)
91. G. Zhang H. T. Zhang Q. Wang P. Lal A. M. Carroll M. de la Llera-Moya X. W. Xu M. I. Greene 2010 Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker Proc. Nat. Acad. Sci. USA 107 732 737 1:CAS:528:DC%2BC3cXhtFCms7w%3D 10.1073/pnas.0911397107 20080743
92. F. S. Zhao J. Dou X. F. He J. Wang L. L. Chu W. H. Hu F. L. Yu K. Hu Y. Wu N. Gu 2010 Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model Vaccine 28 2846 2852 1:CAS:528:DC%2BC3cXjvFCiu7k%3D 10.1016/j.vaccine.2010.01. 057 20153795
93. Y. Y. Zhao Y. Sato T. Isaji T. Fukuda A. Matsumoto E. Miyoshi J. G. Gu N. Taniguchi 2008 Branched N-glycans regulate the biological functions of integrins and cadherins FEBS J. 275 1939 1948 1:CAS:528:DC%2BD1cXlslCrtL4%3D 10.1111/j.1742-4658.2008.06346.x 18384383 (Pubitemid 351569538)
94. P. Zhao M. Wang S. P. Zhang S. C. Shao X. Y. Sun S. D. Yao S. L. Wang 2008 Photochemical properties of a new kind of anti-cancer drug: N-glycoside compound Sci. China Ser. B 51 872 877 1:CAS:528:DC%2BD1cXpvVSqsb4%3D 10.1007/s11426-008-0091-7